Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults

– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin^® / Macrilen^™ in Europe as the Company plans to pursue even greater protection

Read more at globenewswire.com